Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/193358
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorFarràs, Martaes_ES
dc.contributor.authorArranz, Saraes_ES
dc.contributor.authorCarrión, Silviaes_ES
dc.contributor.authorSubirana, Isaaces_ES
dc.contributor.authorMuñoz-Aguayo, Danieles_ES
dc.contributor.authorBlanchart, G.es_ES
dc.contributor.authorKool, Marjones_ES
dc.contributor.authorSolá, Rosaes_ES
dc.contributor.authorMotilva, María-Josées_ES
dc.contributor.authorEscolà-Gil, Joan Carleses_ES
dc.contributor.authorRubió, Lauraes_ES
dc.contributor.authorFernández-Castillejo, Saraes_ES
dc.contributor.authorPedret, Annaes_ES
dc.contributor.authorEstruch, Ramónes_ES
dc.contributor.authorCovas, María Isabeles_ES
dc.contributor.authorFitó, Montserrates_ES
dc.contributor.authorHernáez, Álvaroes_ES
dc.contributor.authorCastañer, Olgaes_ES
dc.date.accessioned2019-10-24T12:18:11Z-
dc.date.available2019-10-24T12:18:11Z-
dc.date.issued2019-07-26-
dc.identifier.citationNutrients 11(8): 1732 (2019)es_ES
dc.identifier.issn2072-6643-
dc.identifier.urihttp://hdl.handle.net/10261/193358-
dc.description.abstractThe consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (p = 0.041 and p = 0.053, versus baseline and the control intervention, respectively), CAV1 (p = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (p = 0.005, p = 0.005, and p = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes.es_ES
dc.description.sponsorshipThis research was funded by: the Spanish Ministry of Economy and Competitiveness (AGL2009-13517-C03-01, AGL2012-40144-C03-01), the Instituto de Salud Carlos III (CB06/03/0028, CB07/08/0016, CD17/00122, CD17/00233, and JR17/00022), FEDER funds (CB06/03), and the Agència de Gestió d’Ajuts Universitaris i de Recerca (2014-SGR-240, 2017-SGR-522)es_ES
dc.language.isoenges_ES
dc.publisherMultidisciplinary Digital Publishing Institutees_ES
dc.relation.isversionofPublisher's versiones_ES
dc.rightsopenAccesses_ES
dc.subjectFunctional virgin olive oiles_ES
dc.subjectOlive oil phenolic compoundses_ES
dc.subjectThyme phenolic compoundses_ES
dc.subjectCholesterol effluxes_ES
dc.subjectHDL cholesteroles_ES
dc.subjectTranscriptomicses_ES
dc.titleA functional virgin olive oil enriched with olive and thyme phenolic compounds improves the expression of cholesterol efflux-related genes: a randomized, cross-over, controlled triales_ES
dc.typeartículoes_ES
dc.identifier.doi10.3390/nu11081732-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.3390/nu11081732es_ES
dc.rights.licensehttp://creativecommons.org/licenses/by-nc-sa/4.0/es_ES
dc.contributor.funderMinisterio de Economía y Competitividad (España)es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderEuropean Commissiones_ES
dc.contributor.funderGeneralitat de Catalunyaes_ES
dc.relation.csices_ES
oprm.item.hasRevisionno ko 0 false*
dc.identifier.funderhttp://dx.doi.org/10.13039/501100000780es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100004587es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100002809es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003329es_ES
dc.contributor.orcidEscolà-Gil, Joan Carles [0000-0001-9021-2485]es_ES
dc.contributor.orcidRubió, Laura [0000-0001-8973-2942]es_ES
dc.identifier.pmid31357534-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextopen-
item.openairetypeartículo-
item.fulltextWith Fulltext-
item.languageiso639-1en-
Aparece en las colecciones: (ICVV) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Functional_Virgin.pdf1,01 MBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

9
checked on 14-abr-2024

SCOPUSTM   
Citations

19
checked on 28-abr-2024

WEB OF SCIENCETM
Citations

15
checked on 27-feb-2024

Page view(s)

339
checked on 02-may-2024

Download(s)

172
checked on 02-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons